{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:28:06Z","timestamp":1746088086431,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["81473492"],"award-info":[{"award-number":["81473492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (CN)","doi-asserted-by":"publisher","award":["81403257"],"award-info":[{"award-number":["81403257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00198-015-3408-3","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T10:09:11Z","timestamp":1447668551000},"page":"1529-1535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with \u03b2-catenin and bone mineral density"],"prefix":"10.1007","volume":"27","author":[{"given":"C.","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. J.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"3408_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1651-2227.1991.tb18152.x","volume":"373","author":"IT Boyle","year":"1991","unstructured":"Boyle IT (1991) Bones for the future. Acta Paediatr Scand Suppl 373:58\u201365","journal-title":"Acta Paediatr Scand Suppl"},{"key":"3408_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1521-690X(02)00080-5","volume":"17","author":"MR McClung","year":"2003","unstructured":"McClung MR (2003) The menopause and HRT. Prevention and management of osteoporosis. Best Pract Res Clin Endocrinol Metab 17:53\u201371","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3408_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1098\/rsif.2009.0282","volume":"7","author":"LM McNamara","year":"2010","unstructured":"McNamara LM (2010) Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J R Soc Interface 7:353\u2013372","journal-title":"J R Soc Interface"},{"key":"3408_CR4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jbmr.242","volume":"26","author":"C Li","year":"2011","unstructured":"Li C, Yang Z, Li Z, Ma Y, Zhang L, Zheng C, Qiu W, Wu X, Wang X, Li H, Tang J, Qian M, Li D, Wang P, Luo J, Liu M (2011) Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-kappaB and MAPK signaling pathways. J Bone Miner Res 26:644\u2013656","journal-title":"J Bone Miner Res"},{"key":"3408_CR5","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"R Baron","year":"2007","unstructured":"Baron R, Rawadi G (2007) Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635\u20132643","journal-title":"Endocrinology"},{"key":"3408_CR6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Invest 116:1202\u20131209","journal-title":"J Clin Invest"},{"key":"3408_CR7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","volume":"57","author":"L Gifre","year":"2013","unstructured":"Gifre L, Ruiz-Gaspa S, Monegal A, Nomdedeu B, Filella X, Guanabens N, Peris P (2013) Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover. Bone 57:272\u2013276","journal-title":"Bone"},{"key":"3408_CR8","first-page":"534352","volume":"2013","author":"XJ Xu","year":"2013","unstructured":"Xu XJ, Shen L, Yang YP, Zhu R, Shuai B, Li CG, Wu MX (2013) Serum beta-catenin levels associated with the ratio of RANKL\/OPG in patients with postmenopausal osteoporosis. Int J Endocrinol 2013:534352","journal-title":"Int J Endocrinol"},{"key":"3408_CR9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3181\/0712-RM-352","volume":"233","author":"L Jin","year":"2008","unstructured":"Jin L, Li Y, Chen CJ, Sherman MA, Le K, Shively JE (2008) Direct interaction of tumor suppressor CEACAM1 with beta catenin: identification of key residues in the long cytoplasmic domain. Exp Biol Med (Maywood) 233:849\u2013859","journal-title":"Exp Biol Med (Maywood)"},{"key":"3408_CR10","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.172.6.3535","volume":"172","author":"D Chen","year":"2004","unstructured":"Chen D, Iijima H, Nagaishi T, Nakajima A, Russell S, Raychowdhury R, Morales V, Rudd CE, Utku N, Blumberg RS (2004) Carcinoembryonic antigen-related cellular adhesion molecule 1 isoforms alternatively inhibit and costimulate human T cell function. J Immunol 172:3535\u20133543","journal-title":"J Immunol"},{"key":"3408_CR11","first-page":"1236","volume":"60","author":"BB Singer","year":"2000","unstructured":"Singer BB, Scheffrahn I, Obrink B (2000) The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. Cancer Res 60:1236\u20131244","journal-title":"Cancer Res"},{"key":"3408_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114360","volume":"9","author":"T Heckt","year":"2014","unstructured":"Heckt T, Bickert T, Jeschke A, Seitz S, Schulze J, Ito WD, Zimmermann W, Amling M, Schinke T, Horst AK, Keller J (2014) Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1. PLoS ONE 9, e114360","journal-title":"PLoS ONE"},{"key":"3408_CR13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood.V96.5.1953","volume":"96","author":"T Michigami","year":"2000","unstructured":"Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T (2000) Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity. Blood 96:1953\u20131960","journal-title":"Blood"},{"key":"3408_CR14","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","volume":"98","author":"RN Pearse","year":"2001","unstructured":"Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, Colman N, Michaeli J, Epstein J, Choi Y (2001) Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A 98:11581\u201311586","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3408_CR15","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1359\/jbmr.2000.15.10.1912","volume":"15","author":"Y Tanaka","year":"2000","unstructured":"Tanaka Y, Maruo A, Fujii K, Nomi M, Nakamura T, Eto S, Minami Y (2000) Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators. J Bone Miner Res 15:1912\u20131923","journal-title":"J Bone Miner Res"},{"key":"3408_CR16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/1521-1878(200011)22:11<961::AID-BIES1>3.0.CO;2-T","volume":"22","author":"N Barker","year":"2000","unstructured":"Barker N, Clevers H (2000) Catenins, Wnt signaling and cancer. BioEssays 22:961\u2013965","journal-title":"BioEssays"},{"key":"3408_CR17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00223-011-9473-5","volume":"88","author":"B Eslami","year":"2011","unstructured":"Eslami B, Zhou S, Van Eekeren I, LeBoff MS, Glowacki J (2011) Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. Calcif Tissue Int 88:272\u2013280","journal-title":"Calcif Tissue Int"},{"key":"3408_CR18","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1073\/pnas.0914360107","volume":"107","author":"U Krause","year":"2010","unstructured":"Krause U, Harris S, Green A, Ylostalo J, Zeitouni S, Lee N, Gregory CA (2010) Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci U S A 107:4147\u20134152","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3408_CR19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0b013e32816e06f9","volume":"19","author":"ML Johnson","year":"2007","unstructured":"Johnson ML, Kamel MA (2007) The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19:376\u2013382","journal-title":"Curr Opin Rheumatol"},{"key":"3408_CR20","doi-asserted-by":"crossref","first-page":"29196","DOI":"10.1074\/jbc.M801907200","volume":"283","author":"N Case","year":"2008","unstructured":"Case N, Ma M, Sen B, Xie Z, Gross TS, Rubin J (2008) Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 283:29196\u201329205","journal-title":"J Biol Chem"},{"key":"3408_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bone.2012.09.029","volume":"52","author":"R Zhang","year":"2013","unstructured":"Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng HW, Zhao M (2013) Wnt\/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52:145\u2013156","journal-title":"Bone"},{"key":"3408_CR22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1359\/jbmr.060316","volume":"21","author":"NH Kulkarni","year":"2006","unstructured":"Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, Frolik CA, Engler T, Wei T, Kriauciunas A, Martin TJ, Sato M, Bryant HU, Ma YL (2006) Orally bioavailable GSK-3alpha\/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21:910\u2013920","journal-title":"J Bone Miner Res"},{"key":"3408_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/adt.2005.3.133","volume":"3","author":"KM Borchert","year":"2005","unstructured":"Borchert KM, Galvin RJ, Frolik CA, Hale LV, Halladay DL, Gonyier RJ, Trask OJ, Nickischer DR, Houck KA (2005) High-content screening assay for activators of the Wnt\/Fzd pathway in primary human cells. Assay Drug Dev Technol 3:133\u2013141","journal-title":"Assay Drug Dev Technol"},{"key":"3408_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1101\/gad.1394306","volume":"20","author":"MA Price","year":"2006","unstructured":"Price MA (2006) CKI, there's more than one: casein kinase I family members in Wnt and hedgehog signaling. Genes Dev 20:399\u2013410","journal-title":"Genes Dev"},{"key":"3408_CR25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/BST0320803","volume":"32","author":"S Patel","year":"2004","unstructured":"Patel S, Doble B, Woodgett JR (2004) Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem Soc Trans 32:803\u2013808","journal-title":"Biochem Soc Trans"},{"key":"3408_CR26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bone.2009.12.020","volume":"46","author":"SKMHM Huang","year":"2010","unstructured":"Huang SKMHM (2010) Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone 46:1138\u20131145","journal-title":"Bone"},{"key":"3408_CR27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1074\/jbc.M108415200","volume":"277","author":"MN Poy","year":"2002","unstructured":"Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM (2002) Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem 277:1076\u20131084","journal-title":"J Biol Chem"},{"key":"3408_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","volume":"18","author":"K Kuespert","year":"2006","unstructured":"Kuespert K, Pils S, Hauck CR (2006) CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 18:565\u2013571","journal-title":"Curr Opin Cell Biol"},{"key":"3408_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","volume":"408","author":"JR Arron","year":"2000","unstructured":"Arron JR, Choi Y (2000) Bone versus immune system. Nature 408:535\u2013536","journal-title":"Nature"},{"key":"3408_CR30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2002.0882","volume":"18","author":"B Muller","year":"2002","unstructured":"Muller B (2002) Cytokine imbalance in non-immunological chronic disease. Cytokine 18:334\u2013339","journal-title":"Cytokine"},{"key":"3408_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"3408_CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bone.2010.09.014","volume":"48","author":"LE Mulcahy","year":"2011","unstructured":"Mulcahy LE, Taylor D, Lee TC, Duffy GP (2011) RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone 48:182\u2013188","journal-title":"Bone"},{"key":"3408_CR33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"3408_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","volume":"40","author":"M Asagiri","year":"2007","unstructured":"Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251\u2013264","journal-title":"Bone"},{"key":"3408_CR35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6874-13-7","volume":"13","author":"AW Kung","year":"2013","unstructured":"Kung AW, Fan T, Xu L, Xia WB, Park IH, Kim HS, Chan SP, Lee JK, Koh L, Soong YK, Soontrapa S, Songpatanasilp T, Turajane T, Yates M, Sen S (2013) Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study. BMC Womens Health 13:7","journal-title":"BMC Womens Health"},{"key":"3408_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LR (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279\u2013302","journal-title":"Endocr Rev"},{"key":"3408_CR37","first-page":"332","volume":"54","author":"JL Wang","year":"2011","unstructured":"Wang JL, Sun SZ, Qu X, Liu WJ, Wang YY, Lv CX, Sun JZ, Ma R (2011) Clinicopathological significance of CEACAM1 gene expression in breast cancer. Chin J Physiol 54:332\u2013338","journal-title":"Chin J Physiol"},{"key":"3408_CR38","first-page":"3183","volume":"60","author":"SM Hyder","year":"2000","unstructured":"Hyder SM, Nawaz Z, Chiappetta C, Stancel GM (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60:3183\u20133190","journal-title":"Cancer Res"},{"key":"3408_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1097-2765(00)80426-8","volume":"5","author":"S Ergun","year":"2000","unstructured":"Ergun S, Kilik N, Ziegeler G, Hansen A, Nollau P, Gotze J, Wurmbach JH, Horst A, Weil J, Fernando M, Wagener C (2000) CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 5:311\u2013320","journal-title":"Mol Cell"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3408-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3408-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3408-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:52:40Z","timestamp":1599825160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3408-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3408-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2015,11,16]]}}}